Caloric restriction and exercise "mimetics" Ready for prime time?

Pharmacological Research

Volumn 103, Issue , 2016, Pages 158-166

  Handschin, Christoph ^a  

^a UNIVERSITY OF BASEL   (Switzerland)

Author keywords

AMPK; Caloric restriction; Diet; Exercise; Mimetics; PGC 1 ; PPAR ; Resveratrol; Skeletal muscle

Indexed keywords

5 AMINO 4 IMIDAZOLECARBOXAMIDE RIBOSIDE; AGENTS AFFECTING PROTEIN METABOLISM; ESTROGEN RELATED RECEPTOR GAMMA AGONIST; GSK 4716; HORMONE RECEPTOR STIMULATING AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE KINASE ACTIVATOR; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; METFORMIN; N [2 [3 (1 PIPERAZINYLMETHYL)IMIDAZO[2,1 B]THIAZOL 6 YL]PHENYL] 2 QUINOXALINECARBOXAMIDE; NICOTINAMIDE RIBOSIDE; NUCLEAR RECEPTOR NR1D1 AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA AGONIST; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA AGONIST; RAPAMYCIN; RESVERATROL; SELECTIVE ANDROGEN RECEPTOR MODULATOR; SR 9009; UNCLASSIFIED DRUG;

CALORIC RESTRICTION; CHRONIC DISEASE; DRUG MECHANISM; ENDURANCE; ENERGY EXPENDITURE; EXERCISE; FEASIBILITY STUDY; HUMAN; KINESIOTHERAPY; LIFESTYLE; LONGEVITY; MITOCHONDRIAL RESPIRATION; MUSCLE METABOLISM; NONHUMAN; OBESITY; PHYSICAL ACTIVITY; PRIORITY JOURNAL; RESISTANCE TRAINING; REVIEW; SIGNAL TRANSDUCTION; SURVIVAL RATE; TRANSCRIPTION REGULATION; ANIMAL; ANIMAL EXPERIMENT; DRUG DESIGN;

ANIMALS; CALORIC RESTRICTION; DRUG DESIGN; EXERCISE; HUMANS; PHYSICAL CONDITIONING, ANIMAL;

EID: 84949032138     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2015.11.009     Document Type: Review

References (104)

1. F.W. Booth, M.V. Chakravarthy, S.E. Gordon, and E.E. Spangenburg Waging war on physical inactivity: using modern molecular ammunition against an ancient enemy J. Appl. Physiol. 93 2002 3 30
2. C. Handschin, and B.M. Spiegelman The role of exercise and pgc1 alpha in inflammation and chronic disease Nature 454 2008 463 469
3. T. Fulop, A. Larbi, J.M. Witkowski, J. McElhaney, M. Loeb, A. Mitnitski, and G. Pawelec Aging, frailty and age-related diseases Biogerontology 11 2010 547 563
4. T.J. Marcell Sarcopenia causes, consequences, and preventions J. Gerontol. A Biol. Sci. Med. Sci. 58 2003 M911 M916
5. F.W. Booth, and J.A. Hawley The erosion of physical activity in western societies: an economic death march Diabetologia 58 2015 1730 1734
6. T. Lobstein, R. Jackson-Leach, M.L. Moodie, K.D. Hall, S.L. Gortmaker, B.A. Swinburn, W.P. James, Y. Wang, and K. McPherson Child and adolescent obesity: part of a bigger picture Lancet 385 2015 2510 2520
7. S.J. Olshansky, D.J. Passaro, R.C. Hershow, J. Layden, B.A. Carnes, J. Brody, L. Hayflick, R.N. Butler, D.B. Allison, and D.S. Ludwig A potential decline in life expectancy in the united states in the 21st century N. Engl. J. Med. 352 2005 1138 1145
8. A.K. Kakkar, and N. Dahiya Drug treatment of obesity: current status and future prospects Eur. J. Intern. Med. 26 2015 89 94
9. W.C. Knowler, E. Barrett-Connor, S.E. Fowler, R.F. Hamman, J.M. Lachin, E.A. Walker, and D.M. Nathan Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin N. Engl. J. Med. 346 2002 393 403
10. E.M. Mercken, B.A. Carboneau, S.M. Krzysik-Walker, and R. de Cabo Of mice and men: the benefits of caloric restriction, exercise, and mimetics Ageing Res. Rev. 11 2012 390 398
11. H. Hoppeler, O. Baum, G. Lurman, and M. Mueller Molecular mechanisms of muscle plasticity with exercise Comp. Physiol. 1 2011 1383 1412
12. S. Schnyder, and C. Handschin Skeletal muscle as an endocrine organ: Pgc-1alpha, myokines and exercise Bone 80 2015 115 125
13. G.E. Fraser, and D.J. Shavlik Ten years of life: is it a matter of choice? Arch. Intern. Med. 161 2001 1645 1652
14. F.W. Booth, M.J. Laye, and M.D. Roberts Lifetime sedentary living accelerates some aspects of secondary aging J. Appl. Physiol. 111 2011 1497 1504
15. S.H. Lee, and K.J. Min Caloric restriction and its mimetics BMB Rep. 46 2013 181 187
16. F.W. Booth, and M.J. Laye Lack of adequate appreciation of physical exercise's complexities can pre-empt appropriate design and interpretation in scientific discovery J. Physiol. 587 2009 5527 5539
17. F.W. Booth, C.K. Roberts, and M.J. Laye Lack of exercise is a major cause of chronic diseases Compr. Physiol. 2 2012 1143 1211
18. K. Szafranski, and K. Mekhail The fine line between lifespan extension and shortening in response to caloric restriction Nucleus 5 2014 56 65
19. R.S. Sohal, and M.J. Forster Caloric restriction and the aging process: a critique Free Radic. Biol. Med. 73 2014 366 382
20. L. Fontana, L. Partridge, and V.D. Longo Extending healthy life span - from yeast to humans Science 328 2010 321 326
21. J.A. Mattison, G.S. Roth, T.M. Beasley, E.M. Tilmont, A.M. Handy, R.L. Herbert, D.L. Longo, D.B. Allison, J.E. Young, M. Bryant, D. Barnard, W.F. Ward, W. Qi, D.K. Ingram, and R. de Cabo Impact of caloric restriction on health and survival in rhesus monkeys from the nia study Nature 489 2012 318 321
22. R.J. Colman, R.M. Anderson, S.C. Johnson, E.K. Kastman, K.J. Kosmatka, T.M. Beasley, D.B. Allison, C. Cruzen, H.A. Simmons, J.W. Kemnitz, and R. Weindruch Caloric restriction delays disease onset and mortality in rhesus monkeys Science 325 2009 201 204
23. A.R. Barnosky, K.K. Hoddy, T.G. Unterman, and K.A. Varady Intermittent fasting vs daily calorie restriction for type 2 diabetes prevention: a review of human findings Transl. Res. 164 2014 302 311
24. A. Chaix, A. Zarrinpar, P. Miu, and S. Panda Time-restricted feeding is a preventative and therapeutic intervention against diverse nutritional challenges Cell Metabol. 20 2014 991 1005
25. M.H. van der Wal, T. Jaarsma, D.K. Moser, N.J. Veeger, W.H. van Gilst, and D.J. van Veldhuisen Compliance in heart failure patients: the importance of knowledge and beliefs Eur. Heart J. 27 2006 434 440
26. K. Okita, S. Kinugawa, and H. Tsutsui Exercise intolerance in chronic heart failure-skeletal muscle dysfunction and potential therapies Circ. J. 77 2013 293 300
27. S. Li, and I. Laher Exercise pills: at the starting line Trends Pharmacol. Sci. 2015 10.1016/j.tips.2015.08.014
28. J. Himms-Hagen Exercise in a pill: feasibility of energy expenditure targets Curr. Drug Targets CNS Neurol. Disord. 3 2004 389 409
29. V.A. Narkar, M. Downes, R.T. Yu, E. Embler, Y.X. Wang, E. Banayo, M.M. Mihaylova, M.C. Nelson, Y. Zou, H. Juguilon, H. Kang, R.J. Shaw, and R.M. Evans Ampk and ppardelta agonists are exercise mimetics Cell 134 2008 405 415
30. D.K. Ingram, and G.S. Roth Calorie restriction mimetics: can you have your cake and eat it, too? Ageing Res. Rev. 20 2015 46 62
31. S. Tandon, L.D. Bowers, and M.N. Fedoruk Treating the elite athlete: anti-doping information for the health professional Mo Med. 112 2015 122 128
32. O. de Hon, H. Kuipers, and M. van Bottenburg Prevalence of doping use in elite sports: a review of numbers and method Sports Med. 45 2015 57 69
33. B. Kupr, and C. Handschin Complex coordination of cell plasticity by a pgc-1 a-controlled transcriptional network in skeletal muscle Front. Physiol. 6 2015 325
34. J. Lin, H. Wu, P.T. Tarr, C.Y. Zhang, Z. Wu, O. Boss, L.F. Michael, P. Puigserver, E. Isotani, E.N. Olson, B.B. Lowell, R. Bassel-Duby, and B.M. Spiegelman Transcriptional co-activator pgc-1 alpha drives the formation of slow-twitch muscle fibres Nature 418 2002 797 801
35. C. Handschin, S. Chin, P. Li, F. Liu, E. Maratos-Flier, N.K. Lebrasseur, Z. Yan, and B.M. Spiegelman Skeletal muscle fiber-type switching, exercise intolerance, and myopathy in pgc-1alpha muscle-specific knock-out animals J. Biol. Chem. 282 2007 30014 30021
36. C. Handschin, C.S. Choi, S. Chin, S. Kim, D. Kawamori, A.J. Kurpad, N. Neubauer, J. Hu, V.K. Mootha, Y.B. Kim, R.N. Kulkarni, G.I. Shulman, and B.M. Spiegelman Abnormal glucose homeostasis in skeletal muscle-specific pgc-1alpha knockout mice reveals skeletal muscle-pancreatic beta cell crosstalk J. Clin. Invest. 117 2007 3463 3474
37. K. Svensson, S. Schnyder, V. Albert, B. Cardel, L. Quagliata, L.M. Terracciano, and C. Handschin Resveratrol and srt1720 elicit differential effects in metabolic organs and modulate systemic parameters independently of skeletal muscle peroxisome proliferator-activated receptor gamma co-activator 1alpha (pgc-1alpha) J. Biol. Chem. 290 2015 16059 16076
38. J.L. Bitterman, and J.H. Chung Metabolic effects of resveratrol: addressing the controversies Cell. Mol. Life Sci. 72 2015 1473 1488
39. K.T. Howitz, K.J. Bitterman, H.Y. Cohen, D.W. Lamming, S. Lavu, J.G. Wood, R.E. Zipkin, P. Chung, A. Kisielewski, L.L. Zhang, B. Scherer, and D.A. Sinclair Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan Nature 425 2003 191 196
40. M. Pacholec, J.E. Bleasdale, B. Chrunyk, D. Cunningham, D. Flynn, R.S. Garofalo, D. Griffith, M. Griffor, P. Loulakis, B. Pabst, X. Qiu, B. Stockman, V. Thanabal, A. Varghese, J. Ward, J. Withka, and K. Ahn Srt1720, srt2183, srt1460, and resveratrol are not direct activators of sirt1 J. Biol. Chem. 285 2010 8340 8351
41. C. Canto, Z. Gerhart-Hines, J.N. Feige, M. Lagouge, L. Noriega, J.C. Milne, P.J. Elliott, P. Puigserver, and J. Auwerx Ampk regulates energy expenditure by modulating nad+ metabolism and sirt1 activity Nature 458 2009 1056 1060
42. J.C. Milne, P.D. Lambert, S. Schenk, D.P. Carney, J.J. Smith, D.J. Gagne, L. Jin, O. Boss, R.B. Perni, C.B. Vu, J.E. Bemis, R. Xie, J.S. Disch, P.Y. Ng, J.J. Nunes, A.V. Lynch, H. Yang, H. Galonek, K. Israelian, W. Choy, A. Iffland, S. Lavu, O. Medvedik, D.A. Sinclair, J.M. Olefsky, M.R. Jirousek, P.J. Elliott, and C.H. Westphal Small molecule activators of sirt1 as therapeutics for the treatment of type 2 diabetes Nature 450 2007 712 716
43. Z. Gerhart-Hines, J.T. Rodgers, O. Bare, C. Lerin, S.H. Kim, R. Mostoslavsky, F.W. Alt, Z. Wu, and P. Puigserver Metabolic control of muscle mitochondrial function and fatty acid oxidation through sirt1/pgc-1alpha Embo J. 26 2007 1913 1923
44. Z. Gerhart-Hines, J.E. Dominy Jr., S.M. Blattler, M.P. Jedrychowski, A.S. Banks, J.H. Lim, H. Chim, S.P. Gygi, and P. Puigserver The camp/pka pathway rapidly activates sirt1 to promote fatty acid oxidation independently of changes in nad(+) Mol. Cell 44 2011 851 863
45. J.C. Yoon, P. Puigserver, G. Chen, J. Donovan, Z. Wu, J. Rhee, G. Adelmant, J. Stafford, C.R. Kahn, D.K. Granner, C.B. Newgard, and B.M. Spiegelman Control of hepatic gluconeogenesis through the transcriptional coactivator pgc-1 Nature 413 2001 131 138
46. J.N. Feige, M. Lagouge, C. Canto, A. Strehle, S.M. Houten, J.C. Milne, P.D. Lambert, C. Mataki, P.J. Elliott, and J. Auwerx Specific sirt1 activation mimics low energy levels and protects against diet-induced metabolic disorders by enhancing fat oxidation Cell Metabol. 8 2008 347 358
47. M. Lagouge, C. Argmann, Z. Gerhart-Hines, H. Meziane, C. Lerin, F. Daussin, N. Messadeq, J. Milne, P. Lambert, P. Elliott, B. Geny, M. Laakso, P. Puigserver, and J. Auwerx Resveratrol improves mitochondrial function and protects against metabolic disease by activating sirt1 and pgc-1alpha Cell 127 2006 1109 1122
48. K. Higashida, S.H. Kim, S.R. Jung, M. Asaka, J.O. Holloszy, and D.H. Han Effects of resveratrol and sirt1 on pgc-1 alpha activity and mitochondrial biogenesis: a reevaluation PLoS Biol. 11 2013 e1001603
49. T.D. Scribbans, J.K. Ma, B.A. Edgett, K.A. Vorobej, A.S. Mitchell, J.G. Zelt, C.A. Simpson, J. Quadrilatero, and B.J. Gurd Resveratrol supplementation does not augment performance adaptations or fibre-type-specific responses to high-intensity interval training in humans Appl. Physiol. Nutr. Metabol. 39 2014 1305 1313
50. L. Gliemann, J.F. Schmidt, J. Olesen, R.S. Bienso, S.L. Peronard, S.U. Grandjean, S.P. Mortensen, M. Nyberg, J. Bangsbo, H. Pilegaard, and Y. Hellsten Resveratrol blunts the positive effects of exercise training on cardiovascular health in aged men J. Physiol. 591 2013 5047 5059
51. J. Olesen, L. Gliemann, R. Bienso, J. Schmidt, Y. Hellsten, and H. Pilegaard Exercise training, but not resveratrol, improves metabolic and inflammatory status in skeletal muscle of aged men J. Physiol. 592 2014 1873 1886
52. M. Ristow, K. Zarse, A. Oberbach, N. Kloting, M. Birringer, M. Kiehntopf, M. Stumvoll, C.R. Kahn, and M. Bluher Antioxidants prevent health-promoting effects of physical exercise in humans Proc. Natl. Acad. Sci. U. S. A. 106 2009 8665 8670
53. R. Mounier, M. Theret, L. Lantier, M. Foretz, and B. Viollet Expanding roles for ampk in skeletal muscle plasticity Trends Endocrinol. Metabol. 26 2015 275 286
54. S. Jager, C. Handschin, J. St-Pierre, and B.M. Spiegelman Amp-activated protein kinase (ampk) action in skeletal muscle via direct phosphorylation of pgc-1alpha Proc. Natl. Acad. Sci. U. S. A. 104 2007 12017 12022
55. G. Zhou, R. Myers, Y. Li, Y. Chen, X. Shen, J. Fenyk-Melody, M. Wu, J. Ventre, T. Doebber, N. Fujii, N. Musi, M.F. Hirshman, L.J. Goodyear, and D.E. Moller Role of amp-activated protein kinase in mechanism of metformin action J. Clin. Invest. 108 2001 1167 1174
56. J.A. Hawley, and J.O. Holloszy Exercise: it's the real thing! Nutr. Rev. 67 2009 172 178
57. M. Schuler, F. Ali, C. Chambon, D. Duteil, J.M. Bornert, A. Tardivel, B. Desvergne, W. Wahli, P. Chambon, and D. Metzger Pgc1alpha expression is controlled in skeletal muscles by pparbeta, whose ablation results in fiber-type switching, obesity, and type 2 diabetes Cell Metabol. 4 2006 407 414
58. J. Perez-Schindler, K. Svensson, E. Vargas-Fernandez, G. Santos, W. Wahli, and C. Handschin The coactivator pgc-1alpha regulates skeletal muscle oxidative metabolism independently of the nuclear receptor pparbeta/delta in sedentary mice fed a regular chow diet Diabetologia 57 2014 2405 2412
59. U. Dressel, T.L. Allen, J.B. Pippal, P.R. Rohde, P. Lau, and G.E. Muscat The peroxisome proliferator-activated receptor beta/delta agonist, gw501516, regulates the expression of genes involved in lipid catabolism and energy uncoupling in skeletal muscle cells Mol. Endocrinol. 17 2003 2477 2493
60. G.M. Giordano Attianese, and B. Desvergne Integrative and systemic approaches for evaluating pparbeta/delta (ppard) function Nucl. Recept. Signal. 13 2015 e001
61. V.A. Narkar, W. Fan, M. Downes, R.T. Yu, J.W. Jonker, W.A. Alaynick, E. Banayo, M.S. Karunasiri, S. Lorca, and R.M. Evans Exercise and pgc-1alpha-independent synchronization of type i muscle metabolism and vasculature by errgamma Cell Metabol. 13 2011 283 293
62. S.M. Rangwala, X. Wang, J.A. Calvo, L. Lindsley, Y. Zhang, G. Deyneko, V. Beaulieu, J. Gao, G. Turner, and J. Markovits Estrogen-related receptor gamma is a key regulator of muscle mitochondrial activity and oxidative capacity J. Biol. Chem. 285 2010 22619 22629
63. S. Devarakonda, K. Gupta, M.J. Chalmers, J.F. Hunt, P.R. Griffin, G.D. Van Duyne, and B.M. Spiegelman Disorder-to-order transition underlies the structural basis for the assembly of a transcriptionally active pgc-1alpha/errgamma complex Proc. Natl. Acad. Sci. U. S. A. 108 2011 18678 18683
64. H. Cho, X. Zhao, M. Hatori, R.T. Yu, G.D. Barish, M.T. Lam, L.W. Chong, L. DiTacchio, A.R. Atkins, C.K. Glass, C. Liddle, J. Auwerx, M. Downes, S. Panda, and R.M. Evans Regulation of circadian behaviour and metabolism by rev-erb-alpha and rev-erb-beta Nature 485 2012 123 127
65. E. Woldt, Y. Sebti, L.A. Solt, C. Duhem, S. Lancel, J. Eeckhoute, M.K. Hesselink, C. Paquet, S. Delhaye, Y. Shin, T.M. Kamenecka, G. Schaart, P. Lefebvre, R. Neviere, T.P. Burris, P. Schrauwen, B. Staels, and H. Duez Rev-erb-alpha modulates skeletal muscle oxidative capacity by regulating mitochondrial biogenesis and autophagy Nat. Med. 19 2013 1039 1046
66. C. Liu, S. Li, T. Liu, J. Borjigin, and J.D. Lin Transcriptional coactivator pgc-1 alpha integrates the mammalian clock and energy metabolism Nature 447 2007 477 481
67. L.A. Solt, Y. Wang, S. Banerjee, T. Hughes, D.J. Kojetin, T. Lundasen, Y. Shin, J. Liu, M.D. Cameron, R. Noel, S.H. Yoo, J.S. Takahashi, A.A. Butler, T.M. Kamenecka, and T.P. Burris Regulation of circadian behaviour and metabolism by synthetic rev-erb agonists Nature 485 2012 62 68
68. S. Cohen, J.A. Nathan, and A.L. Goldberg Muscle wasting in disease: molecular mechanisms and promising therapies Nat. Rev. Drug Discov. 14 2015 58 74
69. L.R. Rodino-Klapac, A.M. Haidet, J. Kota, C. Handy, B.K. Kaspar, and J.R. Mendell Inhibition of myostatin with emphasis on follistatin as a therapy for muscle disease Muscle Nerve 39 2009 283 296
70. X. Zhou, J.L. Wang, J. Lu, Y. Song, K.S. Kwak, Q. Jiao, R. Rosenfeld, Q. Chen, T. Boone, W.S. Simonet, D.L. Lacey, A.L. Goldberg, and H.Q. Han Reversal of cancer cachexia and muscle wasting by actriib antagonism leads to prolonged survival Cell 142 2010 531 543
71. H.Q. Han, X. Zhou, W.E. Mitch, and A.L. Goldberg Myostatin/activin pathway antagonism: molecular basis and therapeutic potential Int. J. Biochem. Cell Biol. 45 2013 2333 2347
72. I.J. McEwan Androgen receptor modulators: a marriage of chemistry and biology Future Med. Chem. 5 2013 1109 1120
73. W. Gao Androgen receptor as a therapeutic target Adv. Drug Deliv. Rev. 62 2010 1277 1284
74. S.D. Kunkel, M. Suneja, S.M. Ebert, K.S. Bongers, D.K. Fox, S.E. Malmberg, F. Alipour, R.K. Shields, and C.M. Adams mRNA expression signatures of human skeletal muscle atrophy identify a natural compound that increases muscles mass Cell Metabol. 13 2011 627 638
75. P. Bostrom, J. Wu, M.P. Jedrychowski, A. Korde, L. Ye, J.C. Lo, K.A. Rasbach, E.A. Bostrom, J.H. Choi, J.Z. Long, S. Kajimura, M.C. Zingaretti, B.F. Vind, H. Tu, S. Cinti, K. Hojlund, S.P. Gygi, and B.M. Spiegelman A pgc1-alpha-dependent myokine that drives brown-fat-like development of white fat and thermogenesis Nature 481 2012 463 468
76. R.R. Rao, J.Z. Long, J.P. White, K.J. Svensson, J. Lou, I. Lokurkar, M.P. Jedrychowski, J.L. Ruas, C.D. Wrann, J.C. Lo, D.M. Camera, J. Lachey, S. Gygi, J. Seehra, J.A. Hawley, and B.M. Spiegelman Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis Cell 157 2014 1279 1291
77. R.A. Vaughan, N.P. Gannon, C.M. Mermier, and C.A. Conn Irisin: a unique non-inflammatory myokine in stimulating skeletal muscle metabolism J. Physiol. Biochem. 71 4 2015 679 689
78. L.D. Roberts, P. Bostrom, J.F. O'Sullivan, R.T. Schinzel, G.D. Lewis, A. Dejam, Y.K. Lee, M.J. Palma, S. Calhoun, A. Georgiadi, M.H. Chen, V.S. Ramachandran, M.G. Larson, C. Bouchard, T. Rankinen, A.L. Souza, C.B. Clish, T.J. Wang, J.L. Estall, A.A. Soukas, C.A. Cowan, B.M. Spiegelman, and R.E. Gerszten Beta-aminoisobutyric acid induces browning of white fat and hepatic beta-oxidation and is inversely correlated with cardiometabolic risk factors Cell Metabol. 19 2014 96 108
79. C. Lee, J. Zeng, B.G. Drew, T. Sallam, A. Martin-Montalvo, J. Wan, S.J. Kim, H. Mehta, A.L. Hevener, R. de Cabo, and P. Cohen The mitochondrial-derived peptide mots-c promotes metabolic homeostasis and reduces obesity and insulin resistance Cell Metabol. 21 2015 443 454
80. D.M. Craig, S.P. Ashcroft, M.Y. Belew, B. Stocks, K. Currell, K. Baar, and A. Philp Utilizing small nutrient compounds as enhancers of exercise-induced mitochondrial biogenesis Front. Physiol. 6 2015 296
81. L. Nogueira, I. Ramirez-Sanchez, G.A. Perkins, A. Murphy, P.R. Taub, G. Ceballos, F.J. Villarreal, M.C. Hogan, and M.H. Malek (-)-Epicatechin enhances fatigue resistance and oxidative capacity in mouse muscle J Physiol. 589 2011 4615 4631
82. S. Borniquel, I. Valle, S. Cadenas, S. Lamas, and M. Monsalve Nitric oxide regulates mitochondrial oxidative stress protection via the transcriptional coactivator pgc-1alpha FASEB J. 20 2006 1889 1891
83. S.D. Westerheide, J.D. Bosman, B.N. Mbadugha, T.L. Kawahara, G. Matsumoto, S. Kim, W. Gu, J.P. Devlin, R.B. Silverman, and R.I. Morimoto Celastrols as inducers of the heat shock response and cytoprotection J. Biol. Chem. 279 2004 56053 56060
84. X. Ma, L. Xu, A.T. Alberobello, O. Gavrilova, A. Bagattin, M. Skarulis, J. Liu, T. Finkel, and E. Mueller Celastrol protects against obesity and metabolic dysfunction through activation of a hsf1-pgc1alpha transcriptional axis Cell Metabol. 22 2015 695 708
85. R.A. Miller, D.E. Harrison, C.M. Astle, J.A. Baur, A.R. Boyd, R. de Cabo, E. Fernandez, K. Flurkey, M.A. Javors, J.F. Nelson, C.J. Orihuela, S. Pletcher, Z.D. Sharp, D. Sinclair, J.W. Starnes, J.E. Wilkinson, N.L. Nadon, and R. Strong Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice J. Gerontol. A Biol. Sci. Med. Sci. 66 2011 191 201
86. K.J. Pearson, J.A. Baur, K.N. Lewis, L. Peshkin, N.L. Price, N. Labinskyy, W.R. Swindell, D. Kamara, R.K. Minor, E. Perez, H.A. Jamieson, Y. Zhang, S.R. Dunn, K. Sharma, N. Pleshko, L.A. Woollett, A. Csiszar, Y. Ikeno, D. Le Couteur, P.J. Elliott, K.G. Becker, P. Navas, D.K. Ingram, N.S. Wolf, Z. Ungvari, D.A. Sinclair, and R. de Cabo Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span Cell Metabol. 8 2008 157 168
87. M.G. Novelle, D. Wahl, C. Dieguez, M. Bernier, and R. de Cabo Resveratrol supplementation: where are we now and where should we go? Ageing Res. Rev. 21 2015 1 15
88. E.J. Park, and J.M. Pezzuto The pharmacology of resveratrol in animals and humans Biochim. Biophys. Acta 1852 2015 1071 1113
89. P.C. Tang, Y.F. Ng, S. Ho, M. Gyda, and S.W. Chan Resveratrol and cardiovascular health - promising therapeutic or hopeless illusion Pharmacol. Res. 90 2014 88 115
90. L. Mouchiroud, R.H. Houtkooper, and J. Auwerx Nad(+) metabolism: a therapeutic target for age-related metabolic disease Crit. Rev. Biochem. Mol. Biol. 48 2013 397 408
91. M. Shimobayashi, and M.N. Hall Making new contacts: the mtor network in metabolism and signalling crosstalk Nat. Rev. Mol. Cell Biol. 15 2014 155 162
92. S.M. Blattler, J.T. Cunningham, F. Verdeguer, H. Chim, W. Haas, H. Liu, K. Romanino, M.A. Ruegg, S.P. Gygi, Y. Shi, and P. Puigserver Yin yang 1 deficiency in skeletal muscle protects against rapamycin-induced diabetic-like symptoms through activation of insulin/igf signaling Cell Metabol. 15 2012 505 517
93. A. Martin-Montalvo, E.M. Mercken, S.J. Mitchell, H.H. Palacios, P.L. Mote, M. Scheibye-Knudsen, A.P. Gomes, T.M. Ward, R.K. Minor, M.J. Blouin, M. Schwab, M. Pollak, Y. Zhang, Y. Yu, K.G. Becker, V.A. Bohr, D.K. Ingram, D.A. Sinclair, N.S. Wolf, S.R. Spindler, M. Bernier, and R. de Cabo Metformin improves healthspan and lifespan in mice Nat. Commun. 4 2013 2192
94. E. Check Hayden Anti-ageing pill pushed as bona fide drug Nature 522 2015 265 266
95. J. Grundlingh, P.I. Dargan, M. El-Zanfaly, and D.M. Wood 2,4-Dinitrophenol (dnp): a weight loss agent with significant acute toxicity and risk of death J. Med. Toxicol. 7 2011 205 212
96. A. Kharitonenkov, and R. DiMarchi Fgf21 Revolutions: recent advances illuminating fgf21 biology and medicinal properties Trends Endocrinol. Metabol. 26 2015 608 617
97. Y. Zhang, Y. Xie, E.D. Berglund, K.C. Coate, T.T. He, T. Katafuchi, G. Xiao, M.J. Potthoff, W. Wei, Y. Wan, R.T. Yu, R.M. Evans, S.A. Kliewer, and D.J. Mangelsdorf The starvation hormone, fibroblast growth factor-21, extends lifespan in mice eLife 1 2012 e00065
98. J.A. Calvo, T.G. Daniels, X. Wang, A. Paul, J. Lin, B.M. Spiegelman, S.C. Stevenson, and S.M. Rangwala Muscle-specific expression of ppargamma coactivator-1alpha improves exercise performance and increases peak oxygen uptake J. Appl. Physiol. 104 2008 1304 1312
99. C.S. Choi, D.E. Befroy, R. Codella, S. Kim, R.M. Reznick, Y.J. Hwang, Z.X. Liu, H.Y. Lee, A. Distefano, V.T. Samuel, D. Zhang, G.W. Cline, C. Handschin, J. Lin, K.F. Petersen, B.M. Spiegelman, and G.I. Shulman Paradoxical effects of increased expression of pgc-1alpha on muscle mitochondrial function and insulin-stimulated muscle glucose metabolism Proc. Natl. Acad. Sci. U. S. A. 105 2008 19926 19931
100. S. Summermatter, O. Baum, G. Santos, H. Hoppeler, and C. Handschin Peroxisome proliferator-activated receptor {gamma} coactivator 1{alpha} (pgc-1{alpha}) promotes skeletal muscle lipid refueling in vivo by activating de novo lipogenesis and the pentose phosphate pathway J. Biol. Chem. 285 2010 32793 32800
101. J.J. Dube, F. Amati, M. Stefanovic-Racic, F.G. Toledo, S.E. Sauers, and B.H. Goodpaster Exercise-induced alterations in intramyocellular lipids and insulin resistance: the athlete's paradox revisited Am. J. Physiol. Endocrinol. Metabol. 294 2008 E882 E888
102. S. Summermatter, G. Shui, D. Maag, G. Santos, M.R. Wenk, and C. Handschin Pgc-1 alpha improves glucose homeostasis in skeletal muscle in an activity-dependent manner Diabetes 62 2013 85 95
103. S. Summermatter, and C. Handschin Pgc-1alpha and exercise in the control of body weight Int. J. Obes. (London) 36 2012 1428 1435
104. C. Handschin The biology of pgc-1alpha and its therapeutic potential Trends Pharmacol. Sci. 30 2009 322 329